These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1123 related articles for article (PubMed ID: 18800370)

  • 1. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and association of somatic symptoms in patients with Major Depressive Disorder.
    Vaccarino AL; Sills TL; Evans KR; Kalali AH
    J Affect Disord; 2008 Oct; 110(3):270-6. PubMed ID: 18280580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual anxiety symptoms in depressed primary care patients.
    McIntyre RS; Konarski JZ; Soczynska JK; Kennedy SH
    J Psychiatr Pract; 2007 Mar; 13(2):125-8. PubMed ID: 17414691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.
    Evans KR; Sills T; DeBrota DJ; Gelwicks S; Engelhardt N; Santor D
    J Psychiatr Res; 2004; 38(3):275-84. PubMed ID: 15003433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Yang CH; Liu CY
    J Psychosom Res; 2008 Aug; 65(2):135-42. PubMed ID: 18655858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of depression in Parkinson's disease: the contribution of somatic symptoms to the clinimetric performance of the Hamilton and Montgomery-Asberg rating scales.
    Reijnders JS; Lousberg R; Leentjens AF
    J Psychosom Res; 2010 Jun; 68(6):561-5. PubMed ID: 20488273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depression: the importance of clinical characteristics and treatment response to prognosis.
    Katon W; Unützer J; Russo J
    Depress Anxiety; 2010; 27(1):19-26. PubMed ID: 19798766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY
    Depress Anxiety; 2009; 26(6):583-91. PubMed ID: 19242983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple pain complaints in patients with major depressive disorder.
    Vaccarino AL; Sills TL; Evans KR; Kalali AH
    Psychosom Med; 2009 Feb; 71(2):159-62. PubMed ID: 19073755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
    Ongur D; Farabaugh A; Iosifescu DV; Perlis R; Fava M
    Psychother Psychosom; 2005; 74(3):173-8. PubMed ID: 15832068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep disturbances in relation to fatigue in major depression.
    Ferentinos P; Kontaxakis V; Havaki-Kontaxaki B; Paparrigopoulos T; Dikeos D; Ktonas P; Soldatos C
    J Psychosom Res; 2009 Jan; 66(1):37-42. PubMed ID: 19073291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.